Stocktoria
CYPHERPUNK TECHNOLOGIES INC. CYPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-01-24
CYPHERPUNK TECHNOLOGIES INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.5M |
| R&D expense | $25.7M | $57.2M | $73.2M | $45.0M | $32.2M |
| Operating income | -$41.1M | -$70.1M | -$87.0M | -$56.8M | -$41.4M |
| Interest expense | — | — | — | $54,000 | $41,000 |
| Income tax | $5.3M | $585,000 | — | $147,000 | -$24,000 |
| Net income | $4.8M | -$67.6M | -$81.4M | -$54.6M | -$40.6M |
| EPS (diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 |
| Operating cash flow | -$43.9M | -$60.3M | -$43.8M | -$49.0M | -$35.2M |
| Cash & equivalents | $14.0M | $47.2M | $70.6M | $65.5M | $114.9M |
| Total assets | $163.2M | $49.1M | $72.8M | $70.4M | $117.9M |
| Total liabilities | $9.7M | $14.1M | $12.7M | $11.5M | $10.0M |
| Shareholders' equity | $153.5M | $35.0M | $60.1M | $58.9M | $107.9M |
Source: SEC EDGAR filings · CIK 0001509745 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.